Compare AIT & AXSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AIT | AXSM |
|---|---|---|
| Founded | 1923 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.5B | 10.4B |
| IPO Year | 1994 | 2015 |
| Metric | AIT | AXSM |
|---|---|---|
| Price | $293.34 | $144.46 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 8 | 22 |
| Target Price | ★ $380.00 | $277.86 |
| AVG Volume (30 Days) | 258.8K | ★ 833.1K |
| Earning Date | 10-27-2026 | 11-02-2026 |
| Dividend Yield | ★ 0.67% | N/A |
| EPS Growth | 8.20 | ★ 38.56 |
| EPS | ★ 2.97 | N/A |
| Revenue | ★ $21,485,000.00 | N/A |
| Revenue This Year | $5.90 | $48.74 |
| Revenue Next Year | $5.83 | $59.14 |
| P/E Ratio | $102.22 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $238.72 | $123.50 |
| 52 Week High | $374.80 | $260.19 |
| Indicator | AIT | AXSM |
|---|---|---|
| Relative Strength Index (RSI) | 31.39 | 22.96 |
| Support Level | $252.95 | N/A |
| Resistance Level | $313.91 | $169.11 |
| Average True Range (ATR) | 10.11 | 7.00 |
| MACD | -4.27 | -0.14 |
| Stochastic Oscillator | 1.02 | 32.14 |
Applied Industrial Technologies Inc is a distributor of industrial products to the maintenance, repair, and operations market and the original equipment manufacturing industry. Further, the company provides engineering and design services for industrial and fluid power applications. The products include bearings, power transmission components, fluid power components and systems, industrial rubber products, linear motion components, safety products, oilfield supplies, and other industrial and maintenance supplies. The company's reportable segments are; Service Center Based Distribution which derives key revenue, and Engineered Solutions. Geographically, the company derives its key revenue from the United States and the rest from Canada and other countries.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.